{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T18:47:09Z","timestamp":1788720429121,"version":"build-2803163510"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,5]]},"DOI":"10.7759\/cureus.28787","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T08:58:51Z","timestamp":1662368331000},"source":"Crossref","is-referenced-by-count":11,"title":["Sarcopenia and Endocrine Ageing: Are They Related?"],"prefix":"10.7759","author":[{"given":"Prishita","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1067\/mlc.2001.113504","article-title":"Sarcopenia","volume":"137","author":"Morley JE","year":"2001","unstructured":"Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. Sarcopenia. J Lab Clin Med. 2001, 137:231-43. 10.1067\/mlc.2001.113504","journal-title":"J Lab Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/127362","article-title":"Sarcopenia and age-related endocrine function","volume":"2012","author":"Sakuma K","year":"2012","unstructured":"Sakuma K, Yamaguchi A. Sarcopenia and age-related endocrine function. Int J Endocrinol. 2012, 2012:127362. 10.1155\/2012\/127362","journal-title":"Int J Endocrinol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.19065","article-title":"Correlation of sarcopenia with modified frailty index as a predictor of outcome in critically ill elderly patients: a cross-sectional study","volume":"13","author":"Bhurchandi S","year":"2021","unstructured":"Bhurchandi S, Kumar S, Agrawal S, Acharya S, Jain S, Talwar D, Lomte S. Correlation of sarcopenia with modified frailty index as a predictor of outcome in critically ill elderly patients: a cross-sectional study. Cureus. 2021, 13:e19065. 10.7759\/cureus.19065","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30110-4","article-title":"Frailty and the endocrine system","volume":"6","author":"Clegg A","year":"2018","unstructured":"Clegg A, Hassan-Smith Z. Frailty and the endocrine system. Lancet Diabetes Endocrinol. 2018, 6:743-52. 10.1016\/S2213-8587(18)30110-4","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e328358d59b","article-title":"Sarcopenia in older adults","volume":"24","author":"Walston JD","year":"2012","unstructured":"Walston JD. Sarcopenia in older adults. Curr Opin Rheumatol. 2012, 24:623-7. 10.1097\/BOR.0b013e328358d59b","journal-title":"Curr Opin Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/58.10.m911","article-title":"Sarcopenia: causes, consequences, and preventions","volume":"58","author":"Marcell TJ","year":"2003","unstructured":"Marcell TJ. Sarcopenia: causes, consequences, and preventions. J Gerontol A Biol Sci Med Sci. 2003, 58:M911-6. 10.1093\/gerona\/58.10.m911","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2010.04.004","article-title":"Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy","volume":"9","author":"Buford TW","year":"2010","unstructured":"Buford TW, Anton SD, Judge AR, et al.. Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy. Ageing Res Rev. 2010, 9:369-83. 10.1016\/j.arr.2010.04.004","journal-title":"Ageing Res Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2001.00303.x","article-title":"Alcoholic skeletal muscle myopathy: definitions, features, contribution of neuropathy, impact and diagnosis","volume":"8","author":"Preedy VR","year":"2001","unstructured":"Preedy VR, Adachi J, Ueno Y, et al.. Alcoholic skeletal muscle myopathy: definitions, features, contribution of neuropathy, impact and diagnosis. Eur J Neurol. 2001, 8:677-87. 10.1046\/j.1468-1331.2001.00303.x","journal-title":"Eur J Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-1592","article-title":"Peripheral muscle alterations in non-COPD smokers","volume":"133","author":"Montes de Oca M","year":"2008","unstructured":"Montes de Oca M, Loeb E, Torres SH, De Sanctis J, Hern\u00e1ndez N, T\u00e1lamo C. Peripheral muscle alterations in non-COPD smokers. Chest. 2008, 133:13-8. 10.1378\/chest.07-1592","journal-title":"Chest"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00301.2007","article-title":"Smoking impairs muscle protein synthesis and increases the expression of myostatin and MAFbx in muscle","volume":"293","author":"Petersen AM","year":"2007","unstructured":"Petersen AM, Magkos F, Atherton P, et al.. Smoking impairs muscle protein synthesis and increases the expression of myostatin and MAFbx in muscle. Am J Physiol Endocrinol Metab. 2007, 293:E843-8. 10.1152\/ajpendo.00301.2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2147\/cia.s11473","article-title":"Optimal management of sarcopenia","volume":"5","author":"Burton LA","year":"2010","unstructured":"Burton LA, Sumukadas D. Optimal management of sarcopenia. Clin Interv Aging. 2010, 5:217-28. 10.2147\/cia.s11473","journal-title":"Clin Interv Aging"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-016-0349-4","article-title":"Sarcopenia in daily practice: assessment and management","volume":"16","author":"Beaudart C","year":"2016","unstructured":"Beaudart C, McCloskey E, Bruy\u00e8re O, et al.. Sarcopenia in daily practice: assessment and management. BMC Geriatr. 2016, 16:170. 10.1186\/s12877-016-0349-4","journal-title":"BMC Geriatr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/cld.1111","article-title":"Sarcopenia assessment techniques","volume":"18","author":"Guttikonda D","year":"2021","unstructured":"Guttikonda D, Smith AL. Sarcopenia assessment techniques. Clin Liver Dis (Hoboken). 2021, 18:189-92. 10.1002\/cld.1111","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-021-01818-x","article-title":"Static one-leg standing balance test as a screening tool for low muscle mass in healthy elderly women","volume":"33","author":"Khanal P","year":"2021","unstructured":"Khanal P, He L, Stebbings GK, et al.. Static one-leg standing balance test as a screening tool for low muscle mass in healthy elderly women. Aging Clin Exp Res. 2021, 33:1831-9. 10.1007\/s40520-021-01818-x","journal-title":"Aging Clin Exp Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S149232","article-title":"Sarcopenia: assessment of disease burden and strategies to improve outcomes","volume":"13","author":"Liguori I","year":"2018","unstructured":"Liguori I, Russo G, Aran L, et al.. Sarcopenia: assessment of disease burden and strategies to improve outcomes. Clin Interv Aging. 2018, 13:913-27. 10.2147\/CIA.S149232","journal-title":"Clin Interv Aging"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/9781119597896.ch19","article-title":"Measurements of physical performance","author":"Orlandini L","year":"2021","unstructured":"Orlandini L, Rolland Y, Cesari M. Measurements of physical performance. Sarcopenia. John Wiley & Sons, Ltd, Hoboken; 2021. 10.1002\/9781119597896.ch19"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2015.05.063","article-title":"Assessment of lean mass and physical performance in sarcopenia","volume":"18","author":"Cawthon PM","year":"2015","unstructured":"Cawthon PM. Assessment of lean mass and physical performance in sarcopenia. J Clin Densitom. 2015, 18:467-71. 10.1016\/j.jocd.2015.05.063","journal-title":"J Clin Densitom"},{"key":"ref18","unstructured":"Effects of Aging on the Endocrine System. (2022). https.\/\/www.msdmanuals.com\/en-in\/home\/hormonal-and-metabolic-disorders\/biology-of-the-endocrine-system\/effects-of-agi...."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/path.2110","article-title":"The endocrine system and ageing","volume":"211","author":"Chahal HS","year":"2007","unstructured":"Chahal HS, Drake WM. The endocrine system and ageing. J Pathol. 2007, 211:173-80. 10.1002\/path.2110","journal-title":"J Pathol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/128.2.351S","article-title":"Age-related sarcopenia in humans is associated with reduced synthetic rates of specific muscle proteins","volume":"128","author":"Proctor DN","year":"1998","unstructured":"Proctor DN, Balagopal P, Nair KS. Age-related sarcopenia in humans is associated with reduced synthetic rates of specific muscle proteins. J Nutr. 1998, 128:351S-5S. 10.1093\/jn\/128.2.351S","journal-title":"J Nutr"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1159\/000367692","article-title":"The endocrinology of ageing: a mini-review","volume":"61","author":"Jones CM","year":"2015","unstructured":"Jones CM, Boelaert K. The endocrinology of ageing: a mini-review. Gerontology. 2015, 61:291-300. 10.1159\/000367692","journal-title":"Gerontology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/BF02778064","article-title":"Sarcopenia and hormonal changes","volume":"7","author":"Balagopal P","year":"1997","unstructured":"Balagopal P, Proctor D, Nair KS. Sarcopenia and hormonal changes. Endocrine. 1997, 7:57-60. 10.1007\/BF02778064","journal-title":"Endocrine"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2014.00217","article-title":"Sarcopenia and androgens: a link between pathology and treatment","volume":"5","author":"Basualto-Alarc\u00f3n C","year":"2014","unstructured":"Basualto-Alarc\u00f3n C, Varela D, Duran J, Maass R, Estrada M. Sarcopenia and androgens: a link between pathology and treatment. Front Endocrinol (Lausanne). 2014, 5:217. 10.3389\/fendo.2014.00217","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-020-03236-y","article-title":"Association between sarcopenia and levels of growth hormone and insulin-like growth factor-1 in the elderly","volume":"21","author":"Bian A","year":"2020","unstructured":"Bian A, Ma Y, Zhou X, Guo Y, Wang W, Zhang Y, Wang X. Association between sarcopenia and levels of growth hormone and insulin-like growth factor-1 in the elderly. BMC Musculoskelet Disord. 2020, 21:214. 10.1186\/s12891-020-03236-y","journal-title":"BMC Musculoskelet Disord"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-6507.20.03198-3","article-title":"The endocrinology of sarcopenia and frailty","volume":"46","author":"Kamwa V","year":"2021","unstructured":"Kamwa V, Welch C, Hassan-Smith ZK. The endocrinology of sarcopenia and frailty. Minerva Endocrinol (Torino). 2021, 46:453-68. 10.23736\/S2724-6507.20.03198-3","journal-title":"Minerva Endocrinol (Torino)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061376","article-title":"Regulation of GH and GH signaling by nutrients","volume":"10","author":"Caputo M","year":"2021","unstructured":"Caputo M, Pigni S, Agosti E, Daffara T, Ferrero A, Filigheddu N, Prodam F. Regulation of GH and GH signaling by nutrients. Cells. 2021, 10:10.3390\/cells10061376","journal-title":"Cells"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2010.123","article-title":"The growth hormone receptor: mechanism of activation and clinical implications","volume":"6","author":"Brooks AJ","year":"2010","unstructured":"Brooks AJ, Waters MJ. The growth hormone receptor: mechanism of activation and clinical implications. Nat Rev Endocrinol. 2010, 6:515-25. 10.1038\/nrendo.2010.123","journal-title":"Nat Rev Endocrinol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1006\/mgme.2000.3068","article-title":"Growth hormone (GH), GH receptor, and signal transduction","volume":"71","author":"Kopchick JJ","year":"2000","unstructured":"Kopchick JJ, Andry JM. Growth hormone (GH), GH receptor, and signal transduction. Mol Genet Metab. 2000, 71:293-314. 10.1006\/mgme.2000.3068","journal-title":"Mol Genet Metab"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1006\/dbio.2000.9975","article-title":"Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth","volume":"229","author":"Lupu F","year":"2001","unstructured":"Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol. 2001, 229:141-62. 10.1006\/dbio.2000.9975","journal-title":"Dev Biol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020517","article-title":"Association between the insulin resistance of puberty and the insulin-like growth factor-I\/growth hormone axis","volume":"87","author":"Moran A","year":"2002","unstructured":"Moran A, Jacobs DR Jr, Steinberger J, Cohen P, Hong CP, Prineas R, Sinaiko AR. Association between the insulin resistance of puberty and the insulin-like growth factor-I\/growth hormone axis. J Clin Endocrinol Metab. 2002, 87:4817-20. 10.1210\/jc.2002-020517","journal-title":"J Clin Endocrinol Metab"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.coemr.2019.06.006","article-title":"Hormones and sarcopenia","volume":"9","author":"McKee A","year":"2019","unstructured":"McKee A, Morley JE. Hormones and sarcopenia. Curr Opin Endocr Metab Res. 2019, 9:34-9. 10.1016\/j.coemr.2019.06.006","journal-title":"Curr Opin Endocr Metab Res"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1046\/j.1532-5415.2001.49173.x","article-title":"Growth hormone administration and exercise effects on muscle fiber type and diameter in moderately frail older people","volume":"49","author":"Hennessey JV","year":"2001","unstructured":"Hennessey JV, Chromiak JA, DellaVentura S, et al.. Growth hormone administration and exercise effects on muscle fiber type and diameter in moderately frail older people. J Am Geriatr Soc. 2001, 49:852-8. 10.1046\/j.1532-5415.2001.49173.x","journal-title":"J Am Geriatr Soc"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.867921","article-title":"Musculoskeletal effects of altered GH action","volume":"13","author":"Young JA","year":"2022","unstructured":"Young JA, Zhu S, List EO, Duran-Ortiz S, Slama Y, Berryman DE. Musculoskeletal effects of altered GH action. Front Physiol. 2022, 13:867921. 10.3389\/fphys.2022.867921","journal-title":"Front Physiol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(97)90057-3","article-title":"Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men","volume":"46","author":"Morley JE","year":"1997","unstructured":"Morley JE, Kaiser FE, Perry HM, et al.. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism. 1997, 46:410-3. 10.1016\/S0026-0495(97)90057-3","journal-title":"Metabolism"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0601","article-title":"Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations","volume":"159","author":"Wang C","year":"2008","unstructured":"Wang C, Nieschlag E, Swerdloff R, et al.. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol. 2008, 159:507-14. 10.1530\/EJE-08-0601","journal-title":"Eur J Endocrinol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0b013e32835b6044","article-title":"Sex hormones and sarcopenia in older persons","volume":"16","author":"Maggio M","year":"2013","unstructured":"Maggio M, Lauretani F, Ceda GP. Sex hormones and sarcopenia in older persons. Curr Opin Clin Nutr Metab Care. 2013, 16:3-13. 10.1097\/MCO.0b013e32835b6044","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.08.021","article-title":"Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis","volume":"122","author":"Wagers AJ","year":"2005","unstructured":"Wagers AJ, Conboy IM. Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis. Cell. 2005, 122:659-67. 10.1016\/j.cell.2005.08.021","journal-title":"Cell"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-011-0883-3","article-title":"Androgens and skeletal muscle: cellular and molecular action mechanisms underlying the anabolic actions","volume":"69","author":"Dubois V","year":"2012","unstructured":"Dubois V, Laurent M, Boonen S, Vanderschueren D, Claessens F. Androgens and skeletal muscle: cellular and molecular action mechanisms underlying the anabolic actions. Cell Mol Life Sci. 2012, 69:1651-67. 10.1007\/s00018-011-0883-3","journal-title":"Cell Mol Life Sci"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.5534\/wjmh.180001","article-title":"Testosterone and sarcopenia","volume":"36","author":"Shin MJ","year":"2018","unstructured":"Shin MJ, Jeon YK, Kim IJ. Testosterone and sarcopenia. World J Mens Health. 2018, 36:192-8. 10.5534\/wjmh.180001","journal-title":"World J Mens Health"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.81.10.8855787","article-title":"Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men--a clinical research center study","volume":"81","author":"Brodsky IG","year":"2022","unstructured":"Brodsky IG, Balagopal P, Nair KS. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men--a clinical research center study. J Clin Endocrinol Metab. 2022, 81:3469-75. 10.1210\/jcem.81.10.8855787","journal-title":"J Clin Endocrinol Metab"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2006.10.001","article-title":"Effects of soy protein and resistance exercise on body composition and blood lipids in postmenopausal women","volume":"56","author":"Maesta N","year":"2007","unstructured":"Maesta N, Nahas EA, Nahas-Neto J, Orsatti FL, Fernandes CE, Traiman P, Burini RC. Effects of soy protein and resistance exercise on body composition and blood lipids in postmenopausal women. Maturitas. 2007, 56:350-8. 10.1016\/j.maturitas.2006.10.001","journal-title":"Maturitas"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.2000.279.4.R1165","article-title":"NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes","volume":"279","author":"Li YP","year":"2000","unstructured":"Li YP, Reid MB. NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes. Am J Physiol Regul Integr Comp Physiol. 2000, 279:R1165-70. 10.1152\/ajpregu.2000.279.4.R1165","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1103589","article-title":"Estrogen receptor-alpha deficiency promotes increased TNF-alpha secretion and bacterial killing by murine macrophages in response to microbial stimuli in vitro","volume":"75","author":"Lambert KC","year":"2004","unstructured":"Lambert KC, Curran EM, Judy BM, Lubahn DB, Estes DM. Estrogen receptor-alpha deficiency promotes increased TNF-alpha secretion and bacterial killing by murine macrophages in response to microbial stimuli in vitro. J Leukoc Biol. 2004, 75:1166-72. 10.1189\/jlb.1103589","journal-title":"J Leukoc Biol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-72-2-374","article-title":"Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women","volume":"72","author":"Weissberger AJ","year":"1991","unstructured":"Weissberger AJ, Ho KK, Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab. 1991, 72:374-81. 10.1210\/jcem-72-2-374","journal-title":"J Clin Endocrinol Metab"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2001.81","article-title":"Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy","volume":"9","author":"S\u00f8rensen MB","year":"2001","unstructured":"S\u00f8rensen MB, Rosenfalck AM, H\u00f8jgaard L, Ottesen B. Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy. Obes Res. 2001, 9:622-6. 10.1038\/oby.2001.81","journal-title":"Obes Res"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2015.03.005","article-title":"Ghrelin","volume":"4","author":"M\u00fcller TD","year":"2015","unstructured":"M\u00fcller TD, Nogueiras R, Andermann ML, et al.. Ghrelin. Mol Metab. 2015, 4:437-60. 10.1016\/j.molmet.2015.03.005","journal-title":"Mol Metab"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1038\/35007534","article-title":"Central nervous system control of food intake","volume":"404","author":"Schwartz MW","year":"2000","unstructured":"Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000, 404:661-71. 10.1038\/35007534","journal-title":"Nature"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00012.2004","article-title":"Ghrelin: structure and function","volume":"85","author":"Kojima M","year":"2005","unstructured":"Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev. 2005, 85:495-522. 10.1152\/physrev.00012.2004","journal-title":"Physiol Rev"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2632","article-title":"Unacylated ghrelin enhances satellite cell function and relieves the dystrophic phenotype in Duchenne muscular dystrophy MDX model","volume":"35","author":"Reano S","year":"2017","unstructured":"Reano S, Angelino E, Ferrara M, et al.. Unacylated ghrelin enhances satellite cell function and relieves the dystrophic phenotype in Duchenne muscular dystrophy MDX model. Stem Cells. 2017, 35:1733-46. 10.1002\/stem.2632","journal-title":"Stem Cells"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-010-0011-5","article-title":"Ghrelin for cachexia","volume":"1","author":"Akamizu T","year":"2010","unstructured":"Akamizu T, Kangawa K. Ghrelin for cachexia. J Cachexia Sarcopenia Muscle. 2010, 1:169-76. 10.1007\/s13539-010-0011-5","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2011.01.014","article-title":"Menopause and sarcopenia: a potential role for sex hormones","volume":"68","author":"Messier V","year":"2011","unstructured":"Messier V, Rabasa-Lhoret R, Barbat-Artigas S, Elisha B, Karelis AD, Aubertin-Leheudre M. Menopause and sarcopenia: a potential role for sex hormones. Maturitas. 2011, 68:331-6. 10.1016\/j.maturitas.2011.01.014","journal-title":"Maturitas"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2013.05.036","article-title":"Glucocorticoid-induced skeletal muscle atrophy","volume":"45","author":"Schakman O","year":"2013","unstructured":"Schakman O, Kalista S, Barb\u00e9 C, Loumaye A, Thissen JP. Glucocorticoid-induced skeletal muscle atrophy. Int J Biochem Cell Biol. 2013, 45:2163-72. 10.1016\/j.biocel.2013.05.036","journal-title":"Int J Biochem Cell Biol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2016.09.008","article-title":"Glucocorticoid administration in athletes: performance, metabolism and detection","volume":"115","author":"Collomp K","year":"2016","unstructured":"Collomp K, Arlettaz A, Buisson C, Lecoq AM, Mongongu C. Glucocorticoid administration in athletes: performance, metabolism and detection. Steroids. 2016, 115:193-202. 10.1016\/j.steroids.2016.09.008","journal-title":"Steroids"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1093\/geroni\/igx004.1317","article-title":"The role of skeletal muscle myostatin in sarcopenia in older adults","volume":"1","author":"Ryan AS","year":"2017","unstructured":"Ryan AS, Serra MC, Addison O. The role of skeletal muscle myostatin in sarcopenia in older adults. Innov Aging. 2017, 1:361. 10.1093\/geroni\/igx004.1317","journal-title":"Innov Aging"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mt.6300182","article-title":"Antagonism of myostatin enhances muscle regeneration during sarcopenia","volume":"15","author":"Siriett V","year":"2007","unstructured":"Siriett V, Salerno MS, Berry C, Nicholas G, Bower R, Kambadur R, Sharma M. Antagonism of myostatin enhances muscle regeneration during sarcopenia. Mol Ther. 2007, 15:1463-70. 10.1038\/sj.mt.6300182","journal-title":"Mol Ther"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1126\/science.1069525","article-title":"Induction of cachexia in mice by systemically administered myostatin","volume":"296","author":"Zimmers TA","year":"2002","unstructured":"Zimmers TA, Davies MV, Koniaris LG, et al.. Induction of cachexia in mice by systemically administered myostatin. Science. 2002, 296:1486-8. 10.1126\/science.1069525","journal-title":"Science"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1242\/dev.067587","article-title":"Pax7-expressing satellite cells are indispensable for adult skeletal muscle regeneration","volume":"138","author":"Sambasivan R","year":"2011","unstructured":"Sambasivan R, Yao R, Kissenpfennig A, et al.. Pax7-expressing satellite cells are indispensable for adult skeletal muscle regeneration. Development. 2011, 138:3647-56. 10.1242\/dev.067587","journal-title":"Development"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12828","article-title":"Myeloid cell-derived tumor necrosis factor-alpha promotes sarcopenia and regulates muscle cell fusion with aging muscle fibers","volume":"17","author":"Wang Y","year":"2018","unstructured":"Wang Y, Welc SS, Wehling-Henricks M, Tidball JG. Myeloid cell-derived tumor necrosis factor-alpha promotes sarcopenia and regulates muscle cell fusion with aging muscle fibers. Aging Cell. 2018, 17:e12828. 10.1111\/acel.12828","journal-title":"Aging Cell"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1096\/fj.04-2870fje","article-title":"Muscle fiber specific apoptosis and TNF-alpha signaling in sarcopenia are attenuated by life-long calorie restriction","volume":"19","author":"Phillips T","year":"2005","unstructured":"Phillips T, Leeuwenburgh C. Muscle fiber specific apoptosis and TNF-alpha signaling in sarcopenia are attenuated by life-long calorie restriction. FASEB J. 2005, 19:668-70. 10.1096\/fj.04-2870fje","journal-title":"FASEB J"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.12631","article-title":"Recommendations abstracted from the American Geriatrics Society Consensus Statement on vitamin D for Prevention of Falls and Their Consequences","volume":"62","year":"2014","unstructured":"Recommendations abstracted from the American Geriatrics Society Consensus Statement on vitamin D for Prevention of Falls and Their Consequences. J Am Geriatr Soc. 2014, 62.147-52. 10.1111\/jgs.12631","journal-title":"J Am Geriatr Soc"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/gls221","article-title":"Efficacy of whey protein supplementation on resistance exercise-induced changes in lean mass, muscle strength, and physical function in mobility-limited older adults","volume":"68","author":"Chal\u00e9 A","year":"2013","unstructured":"Chal\u00e9 A, Cloutier GJ, Hau C, Phillips EM, Dallal GE, Fielding RA. Efficacy of whey protein supplementation on resistance exercise-induced changes in lean mass, muscle strength, and physical function in mobility-limited older adults. J Gerontol A Biol Sci Med Sci. 2013, 68:682-90. 10.1093\/gerona\/gls221","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2014.04.007","article-title":"Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group","volume":"33","author":"Deutz NE","year":"2014","unstructured":"Deutz NE, Bauer JM, Barazzoni R, et al.. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clin Nutr. 2014, 33:929-36. 10.1016\/j.clnu.2014.04.007","journal-title":"Clin Nutr"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2006.05.001","article-title":"Effects of vitamin D supplementation and exercise training on physical performance in Chilean vitamin D deficient elderly subjects","volume":"41","author":"Bunout D","year":"2006","unstructured":"Bunout D, Barrera G, Leiva L, Gattas V, de la Maza MP, Avenda\u00f1o M, Hirsch S. Effects of vitamin D supplementation and exercise training on physical performance in Chilean vitamin D deficient elderly subjects. Exp Gerontol. 2006, 41:746-52. 10.1016\/j.exger.2006.05.001","journal-title":"Exp Gerontol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1123\/japa.3.4.383","article-title":"Implementing a structured exercise program for frail nursing home residents with dementia: issues and challenges","volume":"4","author":"Binder E","year":"1995","unstructured":"Binder E. Implementing a structured exercise program for frail nursing home residents with dementia: issues and challenges. J Aging Phys Act. 1995, 4:3. 10.1123\/japa.3.4.383","journal-title":"J Aging Phys Act"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1139\/H07-141","article-title":"Resistance training, sarcopenia, and the mitochondrial theory of aging","volume":"33","author":"Johnston AP","year":"2008","unstructured":"Johnston AP, De Lisio M, Parise G. Resistance training, sarcopenia, and the mitochondrial theory of aging. Appl Physiol Nutr Metab. 2008, 33:191-9. 10.1139\/H07-141","journal-title":"Appl Physiol Nutr Metab"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1046\/j.1532-5415.2002.50601.x","article-title":"Effects of exercise training on frailty in community-dwelling older adults: results of a randomized, controlled trial","volume":"50","author":"Binder EF","year":"2002","unstructured":"Binder EF, Schechtman KB, Ehsani AA, et al.. Effects of exercise training on frailty in community-dwelling older adults: results of a randomized, controlled trial. J Am Geriatr Soc. 2002, 50:1921-8. 10.1046\/j.1532-5415.2002.50601.x","journal-title":"J Am Geriatr Soc"},{"key":"ref67","article-title":"Aging and sarcopenia","volume":"7","author":"Thompson DD","year":"2007","unstructured":"Thompson DD. Aging and sarcopenia. J Musculoskelet Neuronal Interact. 2007, 7:344-5.","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13316","article-title":"Safety, pharmacokinetics and pharmacological effects of the selective androgen receptor modulator, GSK2881078, in healthy men and postmenopausal women","volume":"83","author":"Clark RV","year":"2017","unstructured":"Clark RV, Walker AC, Andrews S, Turnbull P, Wald JA, Magee MH. Safety, pharmacokinetics and pharmacological effects of the selective androgen receptor modulator, GSK2881078, in healthy men and postmenopausal women. Br J Clin Pharmacol. 2017, 83:2179-94. 10.1111\/bcp.13316","journal-title":"Br J Clin Pharmacol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2020.1777275","article-title":"Selective androgen receptor modulators (SARMs) as pharmacological treatment for muscle wasting in ongoing clinical trials","volume":"29","author":"Fonseca GW","year":"2020","unstructured":"Fonseca GW, Dworatzek E, Ebner N, Von Haehling S. Selective androgen receptor modulators (SARMs) as pharmacological treatment for muscle wasting in ongoing clinical trials. Expert Opin Investig Drugs. 2020, 29:881-91. 10.1080\/13543784.2020.1777275","journal-title":"Expert Opin Investig Drugs"},{"key":"ref70","unstructured":"Human Growth Hormone And Testosterone In Treating Sarcopenia. (2020). https.\/\/alphahormones.com\/human-growth-hormone-and-testosterone-in-treating-sarcopeniag."},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12472","article-title":"Testosterone therapy induces molecular programming augmenting physiological adaptations to resistance exercise in older men","volume":"10","author":"Gharahdaghi N","year":"2019","unstructured":"Gharahdaghi N, Rudrappa S, Brook MS, et al.. Testosterone therapy induces molecular programming augmenting physiological adaptations to resistance exercise in older men. J Cachexia Sarcopenia Muscle. 2019, 10:1276-94. 10.1002\/jcsm.12472","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1136\/mp.54.5.311","article-title":"Insulin-like growth factor 1 (IGF-1): a growth hormone","volume":"54","author":"Laron Z","year":"2001","unstructured":"Laron Z. Insulin-like growth factor 1 (IGF-1): a growth hormone. Mol Pathol. 2001, 54:311-6. 10.1136\/mp.54.5.311","journal-title":"Mol Pathol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(02)02953-4","article-title":"Inhibition of myostatin in adult mice increases skeletal muscle mass and strength","volume":"300","author":"Whittemore LA","year":"2003","unstructured":"Whittemore LA, Song K, Li X, et al.. Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem Biophys Res Commun. 2003, 300:965-71. 10.1016\/S0006-291X(02)02953-4","journal-title":"Biochem Biophys Res Commun"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glp068","article-title":"Myostatin inhibition enhances the effects of exercise on performance and metabolic outcomes in aged mice","volume":"64","author":"LeBrasseur NK","year":"2009","unstructured":"LeBrasseur NK, Schelhorn TM, Bernardo BL, Cosgrove PG, Loria PM, Brown TA. Myostatin inhibition enhances the effects of exercise on performance and metabolic outcomes in aged mice. J Gerontol A Biol Sci Med Sci. 2009, 64:940-8. 10.1093\/gerona\/glp068","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.17987\/jcsm-cr.v2i1.37","article-title":"Myostatin inhibitors as pharmacological treatment for muscle wasting and muscular dystrophy","volume":"2","author":"Saitoh M","year":"2017","unstructured":"Saitoh M, Ishida J, Ebner N, Anker SD, Springer J, von Haehling S. Myostatin inhibitors as pharmacological treatment for muscle wasting and muscular dystrophy. JCSM Clinical Reports. 2017, 2:1-10. 10.17987\/jcsm-cr.v2i1.37","journal-title":"JCSM Clinical Reports"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/109765-sarcopenia-and-endocrine-ageing-are-they-related","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:40:26Z","timestamp":1707507626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/109765-sarcopenia-and-endocrine-ageing-are-they-related"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":75,"URL":"https:\/\/doi.org\/10.7759\/cureus.28787","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,5]]}}}